Windtree Therapeutics (WINT) Competitors $0.12 +0.02 (+21.83%) As of 10/21/2025 03:48 PM Eastern Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock WINT vs. ADXN, KZIA, GELS, SLXN, COCP, MBIO, ACXP, HOOK, IMCC, and PHXMShould you be buying Windtree Therapeutics stock or one of its competitors? The main competitors of Windtree Therapeutics include Addex Therapeutics (ADXN), Novogen (KZIA), Gelteq (GELS), Silexion Therapeutics (SLXN), Cocrystal Pharma (COCP), Mustang Bio (MBIO), Acurx Pharmaceuticals (ACXP), HOOKIPA Pharma (HOOK), IM Cannabis (IMCC), and PHAXIAM Therapeutics (PHXM). These companies are all part of the "pharmaceutical products" industry. Windtree Therapeutics vs. Its Competitors Addex Therapeutics Novogen Gelteq Silexion Therapeutics Cocrystal Pharma Mustang Bio Acurx Pharmaceuticals HOOKIPA Pharma IM Cannabis PHAXIAM Therapeutics Windtree Therapeutics (NASDAQ:WINT) and Addex Therapeutics (NASDAQ:ADXN) are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their analyst recommendations, valuation, earnings, dividends, institutional ownership, media sentiment, risk and profitability. Do insiders & institutionals believe in WINT or ADXN? 29.3% of Windtree Therapeutics shares are owned by institutional investors. Comparatively, 16.1% of Addex Therapeutics shares are owned by institutional investors. 0.2% of Windtree Therapeutics shares are owned by insiders. Comparatively, 15.0% of Addex Therapeutics shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth. Do analysts recommend WINT or ADXN? Windtree Therapeutics presently has a consensus price target of $350.00, indicating a potential upside of 279,900.00%. Given Windtree Therapeutics' stronger consensus rating and higher possible upside, research analysts clearly believe Windtree Therapeutics is more favorable than Addex Therapeutics.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Windtree Therapeutics 0 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00Addex Therapeutics 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Which has preferable valuation & earnings, WINT or ADXN? Addex Therapeutics has higher revenue and earnings than Windtree Therapeutics. Addex Therapeutics is trading at a lower price-to-earnings ratio than Windtree Therapeutics, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioWindtree TherapeuticsN/AN/A-$1.79M-$823.470.00Addex Therapeutics$460K21.98$8.02M-$0.34-28.06 Does the media favor WINT or ADXN? In the previous week, Addex Therapeutics had 3 more articles in the media than Windtree Therapeutics. MarketBeat recorded 3 mentions for Addex Therapeutics and 0 mentions for Windtree Therapeutics. Addex Therapeutics' average media sentiment score of 0.25 beat Windtree Therapeutics' score of 0.00 indicating that Addex Therapeutics is being referred to more favorably in the news media. Company Overall Sentiment Windtree Therapeutics Neutral Addex Therapeutics Neutral Is WINT or ADXN more profitable? Addex Therapeutics has a net margin of 3,584.49% compared to Windtree Therapeutics' net margin of 0.00%. Addex Therapeutics' return on equity of -68.40% beat Windtree Therapeutics' return on equity.Company Net Margins Return on Equity Return on Assets Windtree TherapeuticsN/A -207.34% -50.19% Addex Therapeutics 3,584.49%-68.40%-60.68% Which has more volatility & risk, WINT or ADXN? Windtree Therapeutics has a beta of 0.5, meaning that its share price is 50% less volatile than the S&P 500. Comparatively, Addex Therapeutics has a beta of 1.38, meaning that its share price is 38% more volatile than the S&P 500. SummaryAddex Therapeutics beats Windtree Therapeutics on 9 of the 14 factors compared between the two stocks. Get Windtree Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for WINT and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding WINT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart WINT vs. The Competition Export to ExcelMetricWindtree TherapeuticsMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$3.67M$3.47B$6.21B$10.68BDividend YieldN/A2.27%5.72%4.88%P/E Ratio0.0023.0629.1427.23Price / SalesN/A497.37587.91132.66Price / CashN/A47.5937.5161.65Price / Book0.1310.6612.526.59Net Income-$1.79M-$52.56M$3.32B$276.14M7 Day Performance-16.67%2.64%0.77%-0.72%1 Month PerformanceN/A13.86%7.29%2.47%1 Year Performance-99.72%14.85%64.58%33.90% Windtree Therapeutics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)WINTWindtree Therapeutics1.5551 of 5 stars$0.13+21.8%$350.00+279,900.0%-99.8%$3.67MN/A0.0030ADXNAddex Therapeutics1.0817 of 5 stars$8.99-17.9%N/A-7.4%$11.60M$460K-26.4430Gap DownHigh Trading VolumeKZIANovogen3.8036 of 5 stars$7.39+5.6%$16.50+123.3%-74.8%$11.57M$1.51M0.0012News CoveragePositive NewsGELSGelteqN/A$1.26+3.3%N/AN/A$11.51M$100K0.00N/APositive NewsSLXNSilexion Therapeutics3.2638 of 5 stars$3.64+3.4%$75.00+1,960.4%-92.2%$11.01MN/A0.00N/APositive NewsCOCPCocrystal Pharma2.4209 of 5 stars$1.09+1.9%$6.00+450.5%-49.5%$10.99MN/A-0.8810MBIOMustang Bio0.6 of 5 stars$1.57+4.7%N/A-89.4%$10.86MN/A-0.02100ACXPAcurx Pharmaceuticals2.0352 of 5 stars$6.97+2.5%$31.00+344.8%-82.1%$10.78MN/A-0.653News CoverageAnalyst DowngradeShort Interest ↑Gap DownHOOKHOOKIPA Pharma2.9158 of 5 stars$0.870.0%$4.50+417.2%-78.2%$10.60M$9.35M-0.15160IMCCIM Cannabis0.0986 of 5 stars$1.99-1.5%N/A-7.1%$10.60M$52.41M-3.69340Negative NewsPHXMPHAXIAM TherapeuticsN/A$3.10flatN/AN/A$10.58MN/A0.0049 Related Companies and Tools Related Companies ADXN Competitors KZIA Competitors GELS Competitors SLXN Competitors COCP Competitors MBIO Competitors ACXP Competitors HOOK Competitors IMCC Competitors PHXM Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:WINT) was last updated on 10/22/2025 by MarketBeat.com Staff From Our PartnersIs Nvidia about to Trigger Another 150X Opportunity?Nvidia gave investors a chance to make more than 150 times their money with its AI chips, known as graphics pr...InvestorPlace | SponsoredNEW LAW: Congress Approves Setup For Digital Dollar?Trump Ally Says Congress Approved the Setup for a Digital Dollar 2.0 But according to Rep. Marjorie Taylor ...Goldco Precious Metals | SponsoredBuy UBER immediatelyBULLISH: It's time to buy this 'hidden' AI stock An award-winning stock-rating system has turned BULLISH on...Chaikin Analytics | SponsoredTesla to LEAVE the car market?Elon Musk says November 6 could "affect the future of the world" Get ready for the biggest pivot in corpora...Altimetry | Sponsored$15 Fund: Turn Gold Boom into Real IncomeIf you've been watching gold's historic run and wondering if it's too late… I've got good news. Because the...Investors Alley | SponsoredWhy More Investors Are Using Family Trusts to Protect Their WealthFor many investors, a family trust can be an essential tool for protecting assets, avoiding probate, and ensur...SmartAsset | SponsoredNext opportunity for crypto millionsThe floodgates have opened. Bitcoin and Ethereum ETFs are seeing record-breaking inflows, the biggest since...Crypto 101 Media | SponsoredOptions Pro Reveals His #1 Retirement Income TradeIf you can be at your computer between 9 a.m. and 10:45 a.m. on most weekdays, I’ll show you a simple trading ...Base Camp Trading | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Windtree Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Windtree Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free WINT Stock Alerts